0000950170-24-025888.txt : 20240305
0000950170-24-025888.hdr.sgml : 20240305
20240305160827
ACCESSION NUMBER: 0000950170-24-025888
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240303
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kalif Eliyahu Sharon
CENTRAL INDEX KEY: 0001798443
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16174
FILM NUMBER: 24720360
MAIL ADDRESS:
STREET 1: C/O TEVA, 5 BASEL STREET, P.O. BOX 3190
CITY: PETACH TIKVA
STATE: L3
ZIP: 4951033
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEVA PHARMACEUTICAL INDUSTRIES LTD
CENTRAL INDEX KEY: 0000818686
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 124 DVORA HANEVI'A ST.
CITY: TEL AVIV
STATE: L3
ZIP: 6944020
BUSINESS PHONE: 972 (3) 914-8213
MAIL ADDRESS:
STREET 1: TEVA PHARMACEUTICAL INDUSTRIES LIMITED
STREET 2: 124 DVORA HANEVI'A ST.
CITY: TEL AVIV
STATE: L3
ZIP: 6944020
4
1
ownership.xml
4
X0508
4
2024-03-03
0000818686
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
0001798443
Kalif Eliyahu Sharon
C/O TEVA PHARMACEUTICAL INDUSTRIES LTD.
124 DVORA HANEVI'A ST.,
TEL AVIV
L3
6944020
ISRAEL
false
true
false
false
EVP, Chief Financial Officer
false
Ordinary Shares
2024-03-03
4
M
false
49800
A
174022
D
Ordinary Shares
2024-03-04
4
M
false
33512
A
207534
D
Restricted Share Units
2024-03-03
4
M
false
49800
0
D
Ordinary Shares
49800
174022
D
Restricted Share Units
2024-03-04
4
M
false
33512
0
D
Ordinary Shares
33512
207534
D
Restricted Share Units
2024-03-04
4
A
false
93005
0
A
Ordinary Shares
93005
93005
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
Restricted share units were granted on March 3, 2023, with 49,800 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 49,802 vesting on March 3, 2027.
Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026.
Restricted share units were granted on March 4, 2024, with 23,251 vesting on each of March 4, 2025, March 4, 2026 and March 4, 2027, and 23,252 vesting on March 4, 2028.
/s/ Dov Bergwerk as attorney-in-fact for Eliyahu Sharon Kalif
2024-03-05